Carlsmed, Inc. (CARL)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$15.60+0.52%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · CARL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenues | 63.3 | 50.5 | 27.2 | — |
| Cost of Revenues | 14.8 | 12.5 | 7.1 | — |
| Gross Profit | 48.5 | 38.0 | 20.0 | — |
| Operating Expenses & Income | ||||
| R&D Expenses | 20.9 | 17.0 | 14.3 | — |
| Operating Income | (38.7) | (30.6) | (24.1) | — |
| Earnings from Continuing Operations | ||||
| Interest Expense | 1.3 | 1.4 | 1.3 | — |
| Interest & Investment Income | 3.7 | 2.7 | 1.3 | — |
| Net Interest Expenses | — | — | (0.0) | — |
| Income Tax Expense | — | — | 0.0 | — |
| Net Income | ||||
| Net Income | (36.3) | (29.6) | (24.3) | — |
| Per Share | ||||
| Basic EPS | (1.34) | (2.12) | (6.11) | — |
| Diluted EPS | (1.34) | (2.12) | (6.11) | — |
| Revenue per Share | 2.33 | — | — | — |
| Basic Weighted Avg Shares | 27.2 | 14.2 | 4.1 | — |
| Diluted Weighted Avg Shares | 27.2 | 14.2 | 4.1 | — |
| Supplemental | ||||
| EBITDA | — | (30.3) | (24.0) | — |
| EBIT | (38.7) | (30.6) | (24.1) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.